Auro Laboratories Limited

This company manufactures and trades APIs, intermediates, and generic formulations for various drugs and specialty chemicals.

1989 | Thane, Maharashtra (India) | Active
Last Updated: December 24, 2024

Auro Laboratories Profile

Key Indicators

  • Authorised Capital ₹ 7.00 Cr
  • Paid Up Capital ₹ 6.23 Cr
  • Company Age 35 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 47.16 Cr
  • Satisfied Charges ₹ 8.37 Cr
  • Revenue Growth -5.55%
  • Profit Growth -60.38%
  • Ebitda -58.86%
  • Net Worth 10.28%
  • Total Assets 31.19%

About Auro Laboratories

Auro Laboratories Limited (ALL) is a leading Public Limited Indian Non-Government Company incorporated in India on 26 May 1989 and has a history of 35 years and eight months. Its registered office is in Thane, Maharashtra, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530233.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.23 Cr.

The company currently has active open charges totaling ₹47.16 Cr. The company has closed loans amounting to ₹8.37 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Auro Laboratories Limited India is Shaan Jain as CFO. Sharat Deorah, Siddhartha Deorah, Vishal Jhunjhunwala, and Three other members serve as directors at the Company.

Company Details

  • Location

    Thane, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    L33125MH1989PLC051910

  • Company No.

    051910

  • Stock Symbol

    BSE : 530233

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    26 May 1989

  • Date of AGM

    28 Jun 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Auro Laboratories Limited offer?

Auro Laboratories Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs.

Who are the key members and board of directors at Auro Laboratories?

Executive Team (2)

NameDesignationAppointment DateStatus
Sharat Deorah Country flag representing In Managing Director26-May-1989Current
Shaan Jain CFO13-Jan-2024Current

Board Members (5)

NameDesignationAppointment DateStatus
Vishal Jhunjhunwala Country flag representing In Director 23-Aug-2023Current
Siddhartha Deorah Country flag representing In Whole-Time Director 16-Dec-2013Current
Kavita Sharma Country flag representing In Director 27-Mar-2015Current
Mahendra Daga Country flag representing In Director 01-Apr-2024Current
Kiran Kulkarni Country flag representing In Whole-Time Director 24-May-2021Current

Financial Performance of Auro Laboratories.

Auro Laboratories Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.55% decrease. The company also saw a substantial fall in profitability, with a 60.38% decrease in profit. The company's net worth Soared by an impressive increase of 10.28%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-5.55%
Revenue from Operations
-6.24%
Total Assets
31.19%
Profit or Loss
-60.38%
Net Worth
10.28%
EBITDA
-58.86%

What is the Ownership and Shareholding Structure of Auro Laboratories?

In 2023, Auro Laboratories had a promoter holding of 52.09% and a public holding of 47.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹47.16 Cr

Satisfied Charges

₹8.37 Cr

Charges Breakdown by Lending Institutions

  • Indian Bank : 47.16 Cr

Latest Charge Details

DateLenderAmountStatus
29 Feb 2024Indian Bank₹2.00 MOpen
20 Dec 2002Indian Bank₹46.96 CrOpen
26 Apr 2012Allahabad Bank₹1.00 CrSatisfied
30 Jul 2011Allahabad Bank₹6.00 MSatisfied
30 Jul 2011Allahabad Bank₹6.00 MSatisfied

How Many Employees Work at Auro Laboratories?

Unlock and access historical data on people associated with Auro Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Auro Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auro Laboratories's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Auro Laboratories

Recent activity within the organization

  • Annual General Meeting

    Auro Laboratories Limited last Annual general meeting of members was held on 28 Jun 2024 as per latest MCA records.

    28 Jun 2024

  • Director Appointment

    Mahendra Kumar Daga was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 10 months .

    01 Apr 2024

  • Balance Sheet

    Auro Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

    31 Mar 2024

  • Charges

    A charge with Indian Bank amounted to Rs. 0.20 Cr with Charge ID 100891365 was registered on 29 Feb 2024.

    29 Feb 2024

  • Director Appointment

    Shaan Jain was appointed as a Cfo was appointed as a Cfo on 13 Jan 2024 & has been associated with this company since 1 year 18 days .

    13 Jan 2024

  • Director Appointment

    Vishal Kailashchandra Jhunjhunwala was appointed as a Director was appointed as a Director on 23 Aug 2023 & has been associated with this company since 1 year 5 months .

    23 Aug 2023

Frequently asked questions

  • Auro Laboratories Limited was incorporated on 26 May 1989.

  • The authorized share capital of Auro Laboratories Limited is ₹ 7.00 Cr and paid-up capital is ₹ 6.23 Cr.

  • Currently 7 directors are associated with Auro Laboratories Limited.

    • Sharat Deorah
    • Siddhartha Deorah
    • Vishal Kailashchandra Jhunjhunwala
    • Kavita Vijayakant Sharma
    • Mahendra Kumar Daga
    • Kiran Suresh Kulkarni
    • Shaan Jain
  • As per Ministry of Corporate Affairs (Mca), the registered address of Auro Laboratories Limited is K-56 M I D Ctarapur Industrial Area, India, Thane, Maharashtra, 401506.

  • The corporate identification number (CIN) of Auro Laboratories Limited is L33125MH1989PLC051910 and the company number is 051910 as per Ministry of Corporate Affairs (MCA).

  • Yes, Auro Laboratories Limited is registered on Bombay Stock Exchange (BSE).

  • The Official website of Auro Laboratories Limited is https://www.aurolabs.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Auro Laboratories Limited has fallen by -5.55%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Auro Laboratories Limited has experienced an upsurge of 10.28%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Auro Laboratories Limited amount to ₹ 47.16 Cr.

  • The most recent Balance Sheet for Auro Laboratories Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on API Manufacturers